Centro de Biología Molecular, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, Spain.
PLoS One. 2011 Jan 27;6(1):e16100. doi: 10.1371/journal.pone.0016100.
There is increasing evidence that soluble factors in inflammatory central nervous system diseases not only regulate the inflammatory process but also directly influence electrophysiological membrane properties of neurons and astrocytes. In this context, the cytokine TNF-α (tumor necrosis factor-α) has complex injury promoting, as well as protective, effects on neuronal viability. Up-regulated TNF-α expression has also been found in various neurodegenerative diseases such as cerebral malaria, AIDS dementia, Alzheimer's disease, multiple sclerosis, and stroke, suggesting a potential pathogenic role of TNF-α in these diseases as well. We used the neuroblastoma cells SK-N-MC. Transcriptional activity was measured using luciferase reporter gene assays by using lipofectin. We performed cotransfection experiments of NFAT (nuclear factor of activated T cells) promoter constructed with a dominant negative version of NFAT (dn-NFAT). Cell death was performed by MTT (3-(4,5-dimethylthiazol-2-yl)5,5-diphenyltetrazolium bromide) and TUNEL assays. NFAT translocation was confirmed by Western blot. Involvement of NFAT in cell death was assessed by using VIVIT. P53, Fas-L, caspase-3, and caspase-9 expressions were carried out by Western blot. The mechanisms involved in TNF-α-induced cell death were assessed by using microarray analysis. TNF-α causes neuronal cell death in the absence of glia. TNF-α treatment results in nuclear translocation of NFAT through activation of calcineurin in a Ca(2+) independent manner. We demonstrated the involvement of FasL/Fas, cytochrome c, and caspase-9 but the lack of caspase-3 activation. NB cell death was absolutely reverted in the presence of VIVIT, and partially diminished by anti-Fas treatment. These data demonstrate that TNF-α promotes FasL expression through NFAT activation in neuroblastoma cells and this event leads to increased apoptosis through independent caspase-3 activation.
越来越多的证据表明,炎症性中枢神经系统疾病中的可溶性因子不仅调节炎症过程,而且还直接影响神经元和星形胶质细胞的电生理膜特性。在这种情况下,细胞因子 TNF-α(肿瘤坏死因子-α)对神经元活力具有复杂的促进损伤以及保护作用。在各种神经退行性疾病中,如脑疟疾、艾滋病痴呆、阿尔茨海默病、多发性硬化症和中风,也发现上调的 TNF-α表达,这表明 TNF-α在这些疾病中具有潜在的致病作用。我们使用神经母细胞瘤细胞 SK-N-MC。使用脂质体通过荧光素酶报告基因测定来测量转录活性。我们进行了 cotransfection 实验,使用带有 NFAT(激活的 T 细胞核因子)启动子的 NFAT (dn-NFAT)的显性负版本构建。通过 MTT(3-(4,5-二甲基噻唑-2-基)-5,5-二苯基四唑溴化物)和 TUNEL 测定进行细胞死亡。通过 Western blot 确认 NFAT 易位。通过使用 VIVIT 评估 NFAT 在细胞死亡中的参与。通过 Western blot 进行 P53、Fas-L、caspase-3 和 caspase-9 的表达。通过微阵列分析评估 TNF-α诱导的细胞死亡的机制。TNF-α在没有神经胶质的情况下导致神经元细胞死亡。TNF-α通过钙调神经磷酸酶的激活以 Ca2+ 非依赖性方式导致 NFAT 的核易位。我们证明了 FasL/Fas、细胞色素 c 和 caspase-9 的参与,但缺乏 caspase-3 激活。在 VIVIT 的存在下,NB 细胞死亡绝对逆转,并且通过抗 Fas 处理部分减少。这些数据表明,TNF-α通过 NFAT 激活在神经母细胞瘤细胞中促进 FasL 表达,并且该事件通过独立的 caspase-3 激活导致细胞凋亡增加。